• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NFIB-ERO1A 轴促进乳腺癌转移灶中播散肿瘤细胞的定植。

The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.

机构信息

Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

出版信息

EMBO Mol Med. 2021 Apr 9;13(4):e13162. doi: 10.15252/emmm.202013162. Epub 2021 Mar 10.

DOI:10.15252/emmm.202013162
PMID:33751828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033524/
Abstract

Metastasis is the main cause of deaths related to solid cancers. Active transcriptional programmes are known to regulate the metastatic cascade but the molecular determinants of metastatic colonization remain elusive. Using an inducible piggyBac (PB) transposon mutagenesis screen, we have shown that overexpression of the transcription factor nuclear factor IB (NFIB) alone is sufficient to enhance primary mammary tumour growth and lung metastatic colonization. Mechanistically and functionally, NFIB directly increases expression of the oxidoreductase ERO1A, which enhances HIF1α-VEGFA-mediated angiogenesis and colonization, the last and fatal step of the metastatic cascade. NFIB is thus clinically relevant: it is preferentially expressed in the poor-prognostic group of basal-like breast cancers, and high expression of the NFIB/ERO1A/VEGFA pathway correlates with reduced breast cancer patient survival.

摘要

转移是导致实体癌相关死亡的主要原因。已知活跃的转录程序可以调节转移级联反应,但转移定植的分子决定因素仍难以捉摸。使用可诱导的 piggyBac (PB) 转座子诱变筛选,我们已经表明,转录因子核因子 IB (NFIB) 的过表达本身足以增强原发性乳腺肿瘤的生长和肺转移定植。从机制和功能上讲,NFIB 直接增加了氧化还原酶 ERO1A 的表达,从而增强了 HIF1α-VEGFA 介导的血管生成和定植,这是转移级联反应的最后也是致命的一步。因此,NFIB 具有临床相关性:它在预后不良的基底样乳腺癌组中优先表达,而 NFIB/ERO1A/VEGFA 通路的高表达与降低乳腺癌患者生存率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/21e36cb06aa1/EMMM-13-e13162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/cbd0bfaf2b8a/EMMM-13-e13162-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/6d8565cf1a4f/EMMM-13-e13162-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/104dad912aa6/EMMM-13-e13162-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/f2886c4b2cda/EMMM-13-e13162-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/549c33858c8b/EMMM-13-e13162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/805649c6ccae/EMMM-13-e13162-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/805c55663331/EMMM-13-e13162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/1349653e7afb/EMMM-13-e13162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/8c285fb72e90/EMMM-13-e13162-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/92a21933d759/EMMM-13-e13162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/21e36cb06aa1/EMMM-13-e13162-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/cbd0bfaf2b8a/EMMM-13-e13162-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/6d8565cf1a4f/EMMM-13-e13162-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/104dad912aa6/EMMM-13-e13162-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/f2886c4b2cda/EMMM-13-e13162-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/549c33858c8b/EMMM-13-e13162-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/805649c6ccae/EMMM-13-e13162-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/805c55663331/EMMM-13-e13162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/1349653e7afb/EMMM-13-e13162-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/8c285fb72e90/EMMM-13-e13162-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/92a21933d759/EMMM-13-e13162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/8033524/21e36cb06aa1/EMMM-13-e13162-g004.jpg

相似文献

1
The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.NFIB-ERO1A 轴促进乳腺癌转移灶中播散肿瘤细胞的定植。
EMBO Mol Med. 2021 Apr 9;13(4):e13162. doi: 10.15252/emmm.202013162. Epub 2021 Mar 10.
2
NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.NFIB 通过直接抑制 TP53 突变型三阴性乳腺癌中的 p21 转录来促进细胞存活。
J Pathol. 2019 Feb;247(2):186-198. doi: 10.1002/path.5182. Epub 2018 Dec 18.
3
NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.NCOA1通过同时增强HIF1α和AP-1介导的VEGFa转录来促进乳腺肿瘤中的血管生成。
Oncotarget. 2015 Sep 15;6(27):23890-904. doi: 10.18632/oncotarget.4341.
4
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.NFIB过表达与Rb/p53缺失协同作用促进小细胞肺癌。
Oncotarget. 2016 Sep 6;7(36):57514-57524. doi: 10.18632/oncotarget.11583.
5
NFIB is a potential target for estrogen receptor-negative breast cancers.NFIB 是雌激素受体阴性乳腺癌的潜在靶点。
Mol Oncol. 2011 Dec;5(6):538-44. doi: 10.1016/j.molonc.2011.08.002. Epub 2011 Aug 8.
6
Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.小细胞肺癌可塑性促成非依赖NFIB的转移。
Cancer Res. 2024 Jan 16;84(2):226-240. doi: 10.1158/0008-5472.CAN-23-1079.
7
MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.乳腺腺样囊性癌中的MYB-NFIB基因融合,特别关注具有基底样特征的实体变体。
Hum Pathol. 2014 Nov;45(11):2270-80. doi: 10.1016/j.humpath.2014.07.013. Epub 2014 Aug 7.
8
Knockdown of PPARδ Induces VEGFA-Mediated Angiogenesis Interaction With ERO1A in Human Colorectal Cancer.敲低PPARδ可诱导人结直肠癌中VEGFA介导的血管生成并与ERO1A相互作用。
Front Oncol. 2021 Oct 12;11:713892. doi: 10.3389/fonc.2021.713892. eCollection 2021.
9
NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.NFIB 在雌激素受体阳性乳腺癌中作为癌基因发挥作用,并且受到 miR-205-5p 的调控。
Pathol Res Pract. 2020 Dec;216(12):153236. doi: 10.1016/j.prp.2020.153236. Epub 2020 Oct 2.
10
Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.涎腺腺样囊性癌中MYB-NFIB嵌合基因表达、肿瘤血管生成及增殖的研究
Odontology. 2018 Jul;106(3):238-244. doi: 10.1007/s10266-017-0326-1. Epub 2017 Dec 14.

引用本文的文献

1
Targeting GSK3β and signaling pathways in breast cancer: role of individual members of miR- 23/24/27 cluster.靶向乳腺癌中的糖原合成酶激酶3β及信号通路:miR-23/24/27簇单个成员的作用
BMC Cancer. 2025 Apr 21;25(1):737. doi: 10.1186/s12885-025-14045-8.
2
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.小分子介导的氧化还原酶ERO1A抑制通过损害肿瘤微环境中的VEGF和PD-L1来抑制侵袭性乳腺癌。
Cell Death Dis. 2025 Feb 17;16(1):105. doi: 10.1038/s41419-025-07426-1.
3
Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer.

本文引用的文献

1
Angiogenesis Analyzer for ImageJ - A comparative morphometric analysis of "Endothelial Tube Formation Assay" and "Fibrin Bead Assay".ImageJ 血管生成分析插件——“血管生成体外实验”和“纤维蛋白珠实验”的对比形态学分析
Sci Rep. 2020 Jul 14;10(1):11568. doi: 10.1038/s41598-020-67289-8.
2
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.转移性乳腺癌的基因组景观突出了突变和特征频率的变化。
Nat Genet. 2019 Oct;51(10):1450-1458. doi: 10.1038/s41588-019-0507-7. Epub 2019 Sep 30.
3
Breast Cancer: Current Perspectives on the Disease Status.
用于预测非小细胞肺癌预后的线粒体相关程序性细胞死亡模式
Front Med. 2025 Feb;19(1):101-120. doi: 10.1007/s11684-024-1093-3. Epub 2024 Nov 22.
4
ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer.ERO1A水平是表皮生长因子受体(EGFR)突变的非小细胞肺癌的一个预后指标。
NPJ Precis Oncol. 2024 Nov 4;8(1):250. doi: 10.1038/s41698-024-00736-1.
5
Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14).建立并鉴定表达 cMYB 的人涎腺腺样囊性癌细胞系(UM-HACC-14、UM-HACC-6)及其相应的患者来源异种移植模型(UM-PDX-HACC-14)。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Oct;138(4):516-531. doi: 10.1016/j.oooo.2024.06.005. Epub 2024 Jun 11.
6
Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.内质网氧化还原酶 1 阿尔法(ERO1α)在人类癌症中的生物学机制和临床意义。
J Exp Clin Cancer Res. 2024 Mar 8;43(1):71. doi: 10.1186/s13046-024-02990-4.
7
A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer.基于内质网应激相关基因的风险特征预测胰腺癌的预后和免疫情况。
Front Mol Biosci. 2023 Nov 29;10:1298077. doi: 10.3389/fmolb.2023.1298077. eCollection 2023.
8
Characterisation of forkhead box protein A3 as a key transcription factor for hepatocyte regeneration.叉头框蛋白A3作为肝细胞再生关键转录因子的特征分析
JHEP Rep. 2023 Sep 12;5(12):100906. doi: 10.1016/j.jhepr.2023.100906. eCollection 2023 Dec.
9
Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer.氧化还原酶 ERO1 的特征:一种蛋白质二硫键的产生者和癌症的支持者。
Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189027. doi: 10.1016/j.bbcan.2023.189027. Epub 2023 Nov 24.
10
Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT.NFIB 通过靶向 NAMPT 下调 miR-182-5p 促进结直肠癌中 NAD+ 的补救合成。
Commun Biol. 2023 Jul 25;6(1):775. doi: 10.1038/s42003-023-05143-z.
乳腺癌:疾病现状的当前观点。
Adv Exp Med Biol. 2019;1152:51-64. doi: 10.1007/978-3-030-20301-6_4.
4
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.致命转移性乳腺癌的基因组和免疫景观。
Cell Rep. 2019 May 28;27(9):2690-2708.e10. doi: 10.1016/j.celrep.2019.04.098.
5
Genomic characterization of metastatic breast cancers.转移性乳腺癌的基因组特征分析。
Nature. 2019 May;569(7757):560-564. doi: 10.1038/s41586-019-1056-z. Epub 2019 May 22.
6
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.猪 Bac 转座子工具用于隐性筛选鉴定小鼠 B 细胞淋巴瘤的驱动基因。
Nat Commun. 2019 Mar 29;10(1):1415. doi: 10.1038/s41467-019-09180-3.
7
Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.内质网驻留氧化酶 ERO1-Lalpha 通过 S1PR1/STAT3/VEGF-A 通路促进肝细胞癌转移和血管生成。
Cell Death Dis. 2018 Oct 30;9(11):1105. doi: 10.1038/s41419-018-1134-4.
8
NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.NFIB 通过直接抑制 TP53 突变型三阴性乳腺癌中的 p21 转录来促进细胞存活。
J Pathol. 2019 Feb;247(2):186-198. doi: 10.1002/path.5182. Epub 2018 Dec 18.
9
Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1-α is a poor prognostic marker for non-small cell lung cancer.蛋白质二硫键异构酶和内质网氧化还原酶1-α的联合表达是非小细胞肺癌的不良预后标志物。
Oncol Lett. 2018 Nov;16(5):5753-5760. doi: 10.3892/ol.2018.9339. Epub 2018 Aug 21.
10
NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.NFIB 通过 Akt/Stat3 信号通路促进胃癌细胞的生长、侵袭、转移和 EMT。
Oncol Rep. 2018 Sep;40(3):1565-1573. doi: 10.3892/or.2018.6574. Epub 2018 Jul 13.